Spectrum of gene mutations in colorectal cancer: Implications for treatment

Medicine and Dentistry

• Anti-Epidermal Growth Factor Receptor 100%
• Colorectal Cancer 66%
• Gene Mutation 66%
• Combination Therapy 66%
• Gene 66%
• Therapeutic Procedure 66%
• Monoclonal Antibody 33%
• Carcinogenesis 33%
• Chemotherapy 33%
• Cancer Growth 33%
• Metastatic Colorectal Cancer 33%
• Immune Checkpoint Inhibitor 33%
• Chemotherapeutic Agent 33%
• Predictive Marker 33%
• Development 33%
• Epidermal Growth Factor Receptor Antibody 33%
• Drug 33%
• Comprehension 33%
• Inpatient 33%
• Targeted Therapy 33%
• Clinical Trial 33%